Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prolactinoma 1 Hyperprolactinemia 1

Interventions

Specimen Handling 641 pembrolizumab 585 Magnetic Resonance Spectroscopy 555 Carboplatin 431 Cyclophosphamide 381 Cisplatin 379 Biopsy 376 Nivolumab 315 Paclitaxel 314 Gemcitabine 308 Radiotherapy 286 Bevacizumab 235 Dexamethasone 218 fludarabine 206 Docetaxel 194 durvalumab 189 Oxaliplatin 189 venetoclax 187 Rituximab 175 Fluorouracil 175 atezolizumab 172 Pemetrexed 167 Capecitabine 164 Radiosurgery 162 Doxorubicin 162 Radiation 160 Ipilimumab 146 Lenalidomide 140 Leucovorin 138 Etoposide 134

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cabergoline × 90 days × Clear all

NCT07463235 2026-03-13

SPARAGMOS

University of Sao Paulo General Hospital

Phase 3 Recruiting

Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡